September 29, 2011
SymBio Pharmaceuticals Limited
Fuminori Yoshida
Representative Director
President and Chief Executive Officer

Amount to Be Paid for New Shares and Tentative Terms for Book Building
A resolution was passed at the Board of Directors Meeting held on September 29, 2011 regarding
the amount to be paid for new shares and tentative terms of the Company’s public offering ofnew shares as follows:

１．Public Offering of New Shares（1） Amount to be paid per share

（2）
（3）
（4）

Total Amount to be paid fornew shares
Tentative price range
Rationale behind tentative
price range391 JPY per share（new issuance to be cancelled in case of subscription
price below amount to be paid per share）
1,994,100,000 JPY
460 JPY to 560 JPY
Tentative price range determined based on:- Company’s business activities- Company’s operating results/financial situation- Comparison with other firms- Opinions of and demand by qualified institutional
investors- Current situation of stock market/share price of otherIPOs- Risk of price change prior to listing date, etc.

２．Share Issuance by the Allocation of New Shares to a Third Party（1） Amount to be paid per share
391 JPY per share（2） Total Amount to be paid for
299,115,000 JPY
new shares[Contact]Hiroki Maekawa
Board Director, Corporate Officer, Chief Financial Officer
Tel: +081(0)3 5472 1125

Note: This document is intended for the public release of information only, and not to attract
investment. Please refer to the Company’s prospectus on new stock issuance for future
investment opportunities.
-1-

[Appendix]
１．Public Offering of New Shares（1） Number of offering shares
Equity offering（2） Demand declaration period（3） Price fixing date（4） Application period（5）（6）

Due date of stock payment
Due date for delivery of shares

5,100,000 common shares
765,000 common shares by over-allotment(*)
October 3 to October 7, 2011
October 11, 2011
October 12 to October 17, 2011
October 19, 2011
October 20, 2011(*) Equity Offering by Over-Allotment
This equity offering is set at the maximum number of shares. However, depending on investor
demand, this number may be reduced or the equity offering may be cancelled.
The underwriter (Mitsubishi Morgan Stanley Securities, “MUMSS”) will borrow shares up to aceiling of 765,000 shares from representative director Fuminori Yoshida, the Company’sshareholder, for the equity offering (called “over-allotment”). Regarding this equity offering, theresolution of share issuance by the allocation of new shares to a third party was passed at theBoard of Directors Meeting held on September 14, 2011.
In addition, MUMSS may purchase common shares from the Osaka Securities Exchange during
the period from October 20 to November 11 up to the maximum number of offering shares in orderto return the shares to the borrower (“Syndicate Cover Transaction”) .
In the case that MUMSS decides to purchase common shares from the Osaka Securities
Exchange during the Syndicate Cover Transaction period from October 20 to November 11,
MUMSS may decide not to accept new shares issued by the allocation of new shares to a third
party by over-allotment, decreasing the total equity offering.

Note: This document is intended for the public release of information only, and not to attract
investment. Please refer to the Company’s prospectus on new stock issuance for future
investment opportunities.
-2-